Archive for June, 2012



Smith & Nephew pulls metal-on-metal hip component

Smith & Nephew is withdrawing the optional metal liner, or cup, component of its R3 Acetabular System all-metal artificial hip systems, following a higher than normal level of patient problems with the device. The decision follows an analysis of clinical results showing that 1.6 percent of patients with the system needed revision surgery each year.

Read more about the Smith and Nephew hip replacement recall…

Yaz and Yasmin settlements total surpasses $140 million

Drug manufacturer Bayer AG announced in a stockholder’s newsletter that it has paid $142 million to settle Yaz and Yasmin lawsuits filed against the company. The German company settled over 500 lawsuits alleging that the two birth control pills caused severe injuries to patients, including blood clots and pulmonary embolism.

Read more about the Yasmin and Yaz settlements…

J&J announces it will halt sale of transvaginal mesh implants

Johnson & Johnson has announced that it will stop selling four models of transvaginal surgical mesh implants following numerous lawsuits by women who allege that they were injured by these products. More than 1,000 transvaginal mesh lawsuits have already been filed against Ethicon, a division of Johnson & Johnson that makes surgical mesh products for transvaginal repair surgery.

Read more about the transvaginal mesh announcement…

Actos users with bladder cancer may qualify for a lawsuit

Patients who used the diabetes drug Actos and developed bladder cancer may qualify to file a lawsuit against the manufacturer of the drug. Multiple studies have warned that patients taking Actos may face an increased risk of developing bladder cancer.

Read more about Actos lawsuits…

Experts weigh Actos alternatives after cancer warning

Two new reports filed by the American College of Physicians and Consumer Reports have found that taking an alternative to the diabetes drug Actos has significant advantages for type II diabetes patients. The physicians found that diabetes medication metformin—which has existed for nearly two decades—is both cheaper and safer than Actos.

Read more about alternatives to Actos…


Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 437 other followers

Contact Us:

Hissey Kientz, LLP

9442 Capital of Texas Hwy N.

Arboretum Plaza One, Suite 400

Austin, Texas 78759

Toll-free: (866) 275-4454

Facsimile: (512) 320-9101

Email: info@hkllp.com

Sponsored By:

Hissey Kientz, LLP (Austin, TX)

Attorney Michael Hissey is responsible for the content of this website.